JP2014532481A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532481A5
JP2014532481A5 JP2014539116A JP2014539116A JP2014532481A5 JP 2014532481 A5 JP2014532481 A5 JP 2014532481A5 JP 2014539116 A JP2014539116 A JP 2014539116A JP 2014539116 A JP2014539116 A JP 2014539116A JP 2014532481 A5 JP2014532481 A5 JP 2014532481A5
Authority
JP
Japan
Prior art keywords
composition
polyoxyethylene
weight
polyoxypropylene block
block copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014539116A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532481A (ja
JP6095675B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/062437 external-priority patent/WO2013063580A1/en
Publication of JP2014532481A publication Critical patent/JP2014532481A/ja
Publication of JP2014532481A5 publication Critical patent/JP2014532481A5/ja
Application granted granted Critical
Publication of JP6095675B2 publication Critical patent/JP6095675B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014539116A 2011-10-28 2012-10-29 骨止血のための非水性組成物、およびそれらを使用し、製造するための方法 Active JP6095675B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161553032P 2011-10-28 2011-10-28
US61/553,032 2011-10-28
PCT/US2012/062437 WO2013063580A1 (en) 2011-10-28 2012-10-29 Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture

Publications (3)

Publication Number Publication Date
JP2014532481A JP2014532481A (ja) 2014-12-08
JP2014532481A5 true JP2014532481A5 (https=) 2016-01-28
JP6095675B2 JP6095675B2 (ja) 2017-03-15

Family

ID=48168649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539116A Active JP6095675B2 (ja) 2011-10-28 2012-10-29 骨止血のための非水性組成物、およびそれらを使用し、製造するための方法

Country Status (12)

Country Link
US (2) US9512277B2 (https=)
EP (2) EP2771040B1 (https=)
JP (1) JP6095675B2 (https=)
KR (2) KR102068118B1 (https=)
CN (1) CN104010669A (https=)
AU (1) AU2012328415B2 (https=)
BR (1) BR112014010192B1 (https=)
CA (2) CA2853732C (https=)
ES (2) ES2961982T3 (https=)
HK (1) HK1201213A1 (https=)
MX (1) MX359402B (https=)
WO (2) WO2013063580A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101712809B1 (ko) * 2015-03-19 2017-03-08 주식회사 엠아이텍 뼈 지혈용 생체 흡수성 조성물 및 이의 제조 방법
CN105816905B (zh) * 2016-04-15 2020-12-18 广州贝奥吉因生物科技有限公司 一种具有促愈合功能的可吸收骨蜡及其制备方法
CN106039390A (zh) * 2016-05-27 2016-10-26 中国人民解放军第七五医院 一种骨蜡组合物及其制备方法
KR101990069B1 (ko) * 2017-11-28 2019-06-18 ㈜솔시온바이오메디칼 뼈 지혈용품 조성물
CN109125791B (zh) * 2018-09-29 2019-08-30 广州贝奥吉因生物科技有限公司 一种具有促进骨修复功能的可吸收骨蜡及制备方法
KR102220832B1 (ko) 2018-12-13 2021-02-25 건양대학교 산학협력단 세포 독성이 감소된 생체흡수성 뼈 지혈제의 제조방법
KR102211765B1 (ko) * 2019-01-15 2021-02-03 주식회사 테라시온바이오메디칼 흡수성 골 지혈재 조성물 및 이를 이용한 골 지혈재 제조방법
CN111714684A (zh) * 2019-03-19 2020-09-29 广东博与再生医学有限公司 一种骨止血材料及其制备方法
KR102133503B1 (ko) * 2019-08-19 2020-07-13 한스바이오메드 주식회사 골지혈제용 생체 적합성 조성물, 이를 사용하는 치료 방법, 및 이의 제조 방법
US12285546B2 (en) 2019-08-27 2025-04-29 Dof Inc. Animal fat-derived extracellular matrix, and preservation solution of animal fat-derived extracellular matrix
CN114404642A (zh) * 2022-04-01 2022-04-29 天新福（北京）医疗器材股份有限公司 一种可吸收止血骨泥及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3171072D1 (en) * 1981-06-25 1985-07-25 Stroetmann M Serapharm Enriched plasma derivative for promoting wound sealing and wound covering
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
USRE38558E1 (en) 1991-03-19 2004-07-20 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
AU6898996A (en) * 1995-08-21 1997-03-12 Cytrx Corporation Compositions and methods for growth promotion
US6194515B1 (en) * 1997-10-10 2001-02-27 E. I. Du Pont De Nemours And Company Polyacetal composition with improved toughness
US9616150B2 (en) * 1999-10-29 2017-04-11 Children's Hospital Los Angeles Bone hemostasis method and materials
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
WO2003072157A1 (en) * 2002-02-21 2003-09-04 Encelle, Inc. Immobilized bioactive hydrogel matrices as surface coatings
DE10225420A1 (de) * 2002-06-07 2003-12-24 Sanatis Gmbh Strontium-Apatit-Zement-Zubereitungen, die daraus gebildeten Zemente und die Verwendung davon
US20060258560A1 (en) * 2002-09-30 2006-11-16 Chunlin Yang Dry tissue sealant compositions
JP5508661B2 (ja) 2003-02-12 2014-06-04 シンセラ インコーポレイテッド ランダムおよび非ランダムアルキレンオキシドポリマーアロイ組成物
EP1684819A2 (en) * 2003-11-20 2006-08-02 Angiotech International Ag Polymer compositions and methods for their use
CA2571656A1 (en) 2004-06-23 2006-01-05 Angiotech Biomaterials Corporation Methods and crosslinked polymer compositions for cartilage repair
US8603528B2 (en) * 2004-09-16 2013-12-10 Abyrx, Inc. Compositions and method for the reduction of post-operative pain
NZ563557A (en) * 2005-07-25 2011-04-29 Orthocon Inc Compositions and methods for the reduction of post-operative pain
CA2646486A1 (en) * 2006-03-23 2007-09-27 Citagenix Inc. Reverse phase osteoconductive composition
EP2026756B1 (en) 2006-05-22 2020-06-17 Syncera, Inc. Resorbable polymer compositions for use in medicine, dentistry, and surgery
US8309521B2 (en) * 2007-06-19 2012-11-13 Zimmer, Inc. Spacer with a coating thereon for use with an implant device
US8815973B2 (en) * 2007-08-28 2014-08-26 Pioneer Surgical Technology, Inc. Cement products and methods of making and using the same
EP2227212A1 (en) * 2007-12-07 2010-09-15 BioCure, Inc. Bone substitute
GB0801935D0 (en) * 2008-02-01 2008-03-12 Apatech Ltd Porous biomaterial
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
US20100233269A1 (en) * 2009-03-13 2010-09-16 Baxter International, Inc. Mineralized polymer particles and the method for their production
BRPI1014139A2 (pt) * 2009-06-29 2016-04-26 Bender Analytical Holding Bv sistema de liberação de fármacos compreendendo polioxazolina e um agente biotivo.
AU2011239742B2 (en) 2010-04-16 2014-11-27 Apatech Limited Biomaterial
WO2014086996A1 (en) * 2012-12-07 2014-06-12 Baxter International Inc. Hemostatic foam

Similar Documents

Publication Publication Date Title
JP2014532481A5 (https=)
JP2008539306A5 (https=)
JP2013542284A5 (https=)
JP2016534125A5 (https=)
HRP20200407T1 (hr) Terapeutske polimerne nanočestice i postupci dobivanja i korištenja istih
AU2012328415B2 (en) Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture
JP2011521969A5 (https=)
KR101712809B1 (ko) 뼈 지혈용 생체 흡수성 조성물 및 이의 제조 방법
JP2012517987A5 (ja) 吸入用の医薬組成物のｆｐｄ特性を設定する方法
JP2010537989A5 (https=)
JP2010513634A5 (https=)
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
JP2013535505A5 (https=)
CA2816977A1 (en) Compositions and methods relating to reduced mucoadhesion
WO2011042463A3 (en) Pharmaceutical composition comprising poorly soluble active ingredient and hyperbranched polymer
WO2011107970A3 (en) Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect.
ES2935158T3 (es) Composición farmacéutica de nilotinib
JP2009527505A5 (https=)
JP2016503019A5 (https=)
JP2013542981A5 (https=)
RU2019126797A (ru) Составы твердых дозированных лекарственных форм антагониста орексинового рецептора
RU2015122435A (ru) Композиции для ухода за полостью рта, предназначенные для отбеливания
FI3659627T3 (fi) Polyfosfaattifunktionalisoituja epäorgaanisia nanopartikkeleita hemostaattisina koostumuksina ja käyttömenetelmiä
JP2008538751A5 (https=)
CA2797551A1 (en) Melt-granulated fingolimod